Skip to search.
 FTSE 100 Down 1.72%

Kite Pharma, Inc. (KITE)

-NasdaqGS
57.68 Down 2.30(3.83%) 31 Mar 21:00
|After Hours: : 58.25 Up 0.57 (0.99%) 1 Apr 00:59
Add to Portfolio
Prev Close:59.98
Open:59.26
Bid:57.75 x 100
Ask:59.00 x 300
1y Target Est:83.17
Beta:N/A
Next Earnings Date:N/A
Day's Range:57.55 - 60.83
52wk Range:21.00 - 89.21
Volume:1,468,044
Avg Vol (3m):1,401,460
Market Cap:2.41b
P/E (ttm):N/A
EPS (ttm):-1.91
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEDown 3.83%2.41b
CELGDown 3.95%92.29b
NVSDown 2.67%236.53b
PFEDown 0.60%213.22b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.74
Quarterly EPS Est (Mar-15) :0.28
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback